drugset / Trial / NCT05624320

Using AGN-190584 in Subjects Utilizing Single -Use Daily, Contact Lenses

NCT05624320

NaSingle-groupOpen-labelTreatment

Summary

AGN-190584 has gone through many clinical trials showing its safety and effectiveness in individuals from 40-55 years of age. There has been no published data on the use of this product in individuals corrected with contact lenses for distance vision. There are many other applications AGN-190584 could be used for and further studies will show the effectiveness for each.

Timeline

Start
2022-12-01
Primary completion
2023-05-30
Completion
2023-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject AGN-190584 Unknown Other

Indications